<DOC>
	<DOCNO>NCT02867813</DOCNO>
	<brief_summary>The primary clinical hypothesis long-term exposure evolocumab safe well tolerated subject clinically evident atherosclerotic cardiovascular disease ( CVD ) .</brief_summary>
	<brief_title>Further Cardiovascular Outcomes Research With PCSK9 Inhibition Subjects With Elevated Risk Open-label Extension</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Subject provide informed consent initiation studyspecific activities/procedures Subject complete FOURIER ( Study 20110118 ) still receive assign investigational product . Investigational product permanently discontinue FOURIER reason , include adverse event serious adverse event Subject currently receive treatment another investigational device drug study , end treatment another investigational device drug study ( y ) within less 4 week . Other investigational procedure participate study exclude Subject likely available complete protocolrequired study visit procedure and/or comply require study procedure best subject 's investigator 's knowledge Subject history evidence clinically significant disorder , condition , disease , opinion investigator Amgen physician , consult , would pose risk subject safety interfere study evaluation , procedure , completion Subject know sensitivity active substance excipients ( eg , carboxymethylcellulose ) administer dose Female subject pregnant breastfeeding planning become pregnant plan breastfeed treatment evolocumab within 15 week end treatment evolocumab Female subject childbearing potential willing use acceptable method ( ) effective birth control treatment evolocumab additional 15 week end treatment evolocumab exclude</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>High Cholesterol</keyword>
	<keyword>Treatment high cholesterol</keyword>
	<keyword>Lowering cholesterol</keyword>
	<keyword>Lowering high cholesterol</keyword>
	<keyword>Hypercholesterolemia</keyword>
</DOC>